Hostname: page-component-7bb8b95d7b-l4ctd Total loading time: 0 Render date: 2024-09-11T14:05:28.579Z Has data issue: false hasContentIssue false
  • English
  • Français

Response to: Management of Seizures and Epilepsy in Patients with Autoimmune Encephalitis

Published online by Cambridge University Press:  29 April 2024

Chris Hahn Open the ORCID record for Chris Hahn [Opens in a new window] ,
Jennifer A. McCombe Open the ORCID record for Jennifer A. McCombe [Opens in a new window]  and
Adrian Budhram Open the ORCID record for Adrian Budhram [Opens in a new window]
Chris Hahn*
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada
Jennifer A. McCombe
Affiliation:
Division of Neurology, University of Alberta, Edmonton, AB, Canada
Adrian Budhram
Affiliation:
Department of Pathology and Laboratory Medicine, Western University, London Health Sciences Centre, London, ON, Canada Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada
*
Corresponding author: C. Hahn; Email: chahn@ucalgary.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Autoimmune diseaseepilepsyseizures
Type
Letters to the Editor: Published Article
Information
Canadian Journal of Neurological Sciences , First View , pp. 1 - 2
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hahn, C, Budhram, A, Alikhani, K, et al. Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults. Can J Neurol Sci. 2024:1–21.Google ScholarPubMed
de Bruijn, MAAM, van Sonderen, A, van Coevorden-Hameete, MH, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA. Neurology. 2019;92:e2185–e96.CrossRefGoogle ScholarPubMed
Liu, X, Guo, K, Lin, J, et al. Long-term seizure outcomes in patients with autoimmune encephalitis: a prospective observational registry study update. Epilepsia. 2022;63:1812–21.CrossRefGoogle ScholarPubMed
Smith, KM, Britton, JW, Thakolwiboon, S, et al. Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies. Epilepsia. 2023;64:2385–98.CrossRefGoogle ScholarPubMed
Malter, MP, Frisch, C, Zeitler, H, et al. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure. 2015;30:57–63.CrossRefGoogle ScholarPubMed
Serrano-Castro, PJ, Rodríguez-Uranga, JJ, Cabezudo-García, P, et al. Cenobamate and clobazam combination as personalized medicine in autoimmune-associated epilepsy with Anti-Gad65 antibodies. Neurol Neuroimmunol Neuroinflamm. 2023;10:e200151.CrossRefGoogle ScholarPubMed
Mäkelä, KM, Hietaharju, A, Brander, A, Peltola, J. Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs. Front Neurol. 2018;9:579.CrossRefGoogle ScholarPubMed
Carreño, M, Bien, CG, Asadi-Pooya, AA, et al. Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies. Epilepsy Res. 2017;129:101–5.CrossRefGoogle ScholarPubMed